Best TWAS P=2.26e-14 · Best GWAS P=3.85e-12 conditioned to 0.0209
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Colon Sigmoid | ARL14EP | 0.16 | 0.05 | lasso | 13 | 0.10 | 2.6e-04 | 2.8 | -6.3 | 2.8e-10 | 0.68 | 0.07 | 0.66 | FALSE |
2 | GTEx | Esophagus Mucosa | ARL14EP | 0.09 | 0.03 | enet | 11 | 0.05 | 1.8e-04 | 2.8 | -5.5 | 4.4e-08 | 0.56 | 0.16 | 0.64 | FALSE |
3 | GTEx | Spleen | ARL14EP | 0.34 | 0.19 | enet | 24 | 0.30 | 1.7e-08 | 5.4 | -5.3 | 1.1e-07 | 0.42 | 0.36 | 0.34 | FALSE |
4 | GTEx | Stomach | ARL14EP | 0.10 | 0.07 | lasso | 3 | 0.04 | 4.0e-03 | -5.7 | -5.7 | 1.1e-08 | 0.38 | 0.62 | 0.12 | FALSE |
5 | GTEx | Testis | MPPED2 | 0.18 | 0.17 | enet | 15 | 0.17 | 6.9e-08 | 6.4 | 6.0 | 2.7e-09 | 0.02 | 0.14 | 0.86 | TRUE |
6 | GTEx | Testis | ARL14EP | 0.43 | 0.36 | lasso | 3 | 0.37 | 1.8e-17 | -6.9 | -6.7 | 2.1e-11 | 0.84 | 0.01 | 0.99 | FALSE |
7 | GTEx | Thyroid | ARL14EP | 0.20 | 0.05 | lasso | 6 | 0.09 | 1.0e-07 | -6.5 | -6.6 | 4.9e-11 | 0.79 | 0.01 | 0.99 | FALSE |
8 | GTEx | Whole Blood | ARL14EP | 0.07 | 0.05 | lasso | 2 | 0.05 | 3.3e-05 | 5.5 | -5.5 | 2.8e-08 | 0.26 | 0.80 | 0.05 | FALSE |
9 | METSIM | Adipose | ARL14EP | 0.06 | 0.00 | bslmm | 398 | 0.02 | 2.9e-04 | -6.5 | -5.3 | 1.3e-07 | 0.59 | 0.01 | 0.97 | FALSE |
10 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C11orf46 | 0.05 | 0.05 | lasso | 5 | 0.06 | 6.2e-12 | 5.5 | -5.2 | 1.5e-07 | 0.25 | 0.96 | 0.04 | FALSE |
11 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | C11orf46 | 0.36 | 0.27 | lasso | 5 | 0.30 | 8.3e-34 | 5.4 | -5.3 | 1.1e-07 | 0.30 | 0.98 | 0.02 | FALSE |
12 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | C11orf46 | 0.13 | 0.12 | lasso | 3 | 0.11 | 8.9e-07 | 5.4 | -5.4 | 8.4e-08 | 0.26 | 0.94 | 0.03 | FALSE |
13 | The Cancer Genome Atlas | Brain Lower Grade Glioma | C11orf46 | 0.02 | 0.02 | lasso | 2 | 0.02 | 5.9e-03 | -6.8 | -6.8 | 8.6e-12 | 0.99 | 0.00 | 0.78 | FALSE |
14 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | C11orf46 | 0.12 | 0.07 | blup | 34 | 0.07 | 4.4e-04 | 5.4 | -6.8 | 7.6e-12 | 0.68 | 0.05 | 0.35 | FALSE |
15 | The Cancer Genome Atlas | Lung Adenocarcinoma | C11orf46 | 0.09 | 0.11 | lasso | 4 | 0.10 | 1.2e-11 | 5.4 | -5.6 | 2.7e-08 | 0.29 | 0.98 | 0.02 | FALSE |
16 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | C11orf46 | 0.22 | 0.22 | lasso | 3 | 0.20 | 1.1e-08 | 5.4 | -5.4 | 7.0e-08 | 0.26 | 0.97 | 0.02 | FALSE |
17 | The Cancer Genome Atlas | Prostate Adenocarcinoma | C11orf46 | 0.09 | 0.07 | lasso | 2 | 0.06 | 2.4e-07 | 5.4 | -5.4 | 8.0e-08 | 0.26 | 0.95 | 0.02 | FALSE |
18 | The Cancer Genome Atlas | Thyroid Carcinoma | C11orf46 | 0.12 | 0.06 | blup | 34 | 0.10 | 1.4e-09 | 5.4 | -7.6 | 2.3e-14 | 0.71 | 0.69 | 0.31 | TRUE |